To: | Spartan Bioscience Inc. (tmadmin@choate.com) |
Subject: | U.S. Trademark Application Serial No. 88948859 - SPARTAN - 2012519-0012 |
Sent: | September 11, 2020 04:03:26 PM |
Sent As: | ecom117@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88948859
Mark: SPARTAN
|
|
Correspondence Address:
|
|
Applicant: Spartan Bioscience Inc.
|
|
Reference/Docket No. 2012519-0012
Correspondence Email Address: |
|
NONFINAL OFFICE ACTION
The USPTO must receive applicant’s response to this letter within six months of the issue date below or the application will be abandoned. Respond using the Trademark Electronic Application System (TEAS). A link to the appropriate TEAS response form appears at the end of this Office action.
Issue date: September 11, 2020
The referenced application has been reviewed by the assigned trademark examining attorney. Applicant must respond timely and completely to the issue(s) below. 15 U.S.C. §1062(b); 37 C.F.R. §§2.62(a), 2.65(a); TMEP §§711, 718.03.
NO CONFLICTING MARKS
DECLARATION
The following statements must be verified: That applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date; that applicant believes applicant is entitled to use the mark in commerce on or in connection with the goods or services specified in the application; that to the best of the signatory’s knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive; and that the facts set forth in the application are true. 37 C.F.R. §§2.33(b)(2), (c), 2.34(a)(2), (a)(3)(i), (a)(4)(ii).
For more information about the verified statement and instructions on providing one using the online Trademark Electronic Application System (TEAS) response form, see the Verified statement webpage.
(1) Electronic typed signature. In the TEAS signature block, the signer personally types any combination of letters, numbers, spaces, and/or punctuation marks that the signer has adopted as a signature, placed between two forward slash (/) symbols (e.g., /john doe/). And if the filer is not the actual signer of the form, the filer may email the completed unsigned form from within TEAS to the signer to personally type his or her e-signature, after which the form will be automatically returned to the filer for submission.
(2) Pen-and-ink traditional handwritten signature. The filer prints out the completed form in text format and mails or faxes it to the signer who reviews and personally signs and dates it in the usual pen-and-ink manner. The signature and date portion, together with the wording of a declaration under 37 C.F.R. §2.20, if required, is then scanned by the filer as a jpg or pdf image file and attached to the form for submission.
See 37 C.F.R. §2.193(a); TMEP §§611.01(c), 804.03.
In all cases, the signer’s first and last name and title or position must be specified. 37 C.F.R. §2.193(d).
FILING BASIS CLARIFICATION
An application with a Section 44(e) basis must include a true copy, photocopy, certification, or certified copy of a foreign registration from an applicant’s country of origin. 15 U.S.C. §1126(e); 37 C.F.R. §2.34(a)(3)(ii); TMEP §§1004, 1004.01, 1016. In addition, an applicant’s country of origin must be a party to a convention or treaty relating to trademarks to which the United States is also a party, or must extend reciprocal registration rights to nationals of the United States by law. 15 U.S.C. §1126(b); TMEP §§1002.01, 1004.
Therefore, applicant must provide a copy of the foreign registration from applicant’s country of origin when it becomes available. TMEP §1003.04(a). A copy of a foreign registration must consist of a document issued to an applicant by, or certified by, the intellectual property office in applicant’s country of origin. TMEP §1004.01. If applicant’s country of origin does not issue registrations or Madrid Protocol certificates of extension of protection, applicant may submit a copy of the Madrid Protocol international registration that shows that protection of the international registration has been extended to applicant’s country of origin. TMEP §1016. In addition, applicant must also provide an English translation if the foreign registration is not written in English. 37 C.F.R. §2.34(a)(3)(ii); TMEP §1004.01(a)-(b). The translation should be signed by the translator. TMEP §1004.01(b).
If the foreign registration has not yet issued, or applicant requires additional time to procure a copy of the foreign registration (and English translation, as appropriate), applicant should so inform the trademark examining attorney and request that the U.S. application be suspended until a copy of the foreign registration is available. TMEP §§716.02(b), 1003.04(b).
If applicant cannot satisfy the requirements of a Section 44(e) basis, applicant may request that the mark be approved for publication based solely on the Section 1(b) basis. See 15 U.S.C. §§1051(b), 1126(e); 37 C.F.R. §2.35(b)(1); TMEP §§806.02(f), 806.04(b), 1003.04(b). Although the mark may be approved for publication on the Section 1(b) basis, it will not register until an acceptable allegation of use has been filed. See 15 U.S.C. §1051(c)-(d); 37 C.F.R. §§2.76, 2.88; TMEP §1103. Please note that, if the U.S. application satisfied the requirements of Section 44(d) as of the U.S. application filing date, applicant may retain the priority filing date under Section 44(d) without perfecting the Section 44(e) basis, provided there is a continuing valid basis for registration. See 37 C.F.R. §2.35(b)(3)-(4); TMEP §§806.02(f), 806.04(b).
Alternatively, applicant has the option to amend the application to rely solely on the Section 44(e) basis and request deletion of the Section 1(b) basis. See 37 C.F.R. §2.35(b)(1); TMEP §806.04. The foreign registration alone may serve as the basis for obtaining a U.S. registration. See 37 C.F.R. §2.34(a)(3); TMEP §806.01(d).
IDENTIFICATION OF GOODS & SERVICES – INDEFINITE
Applicant may adopt the following identification, if accurate:
“Diagnostic reagents for medical-scientific research use, in International Class 1.”
“Clinical diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic reagents for clinical laboratory use; diagnostic reagents for medical diagnostic use; diagnostic reagents for medical laboratory use; medical diagnostic reagents; medical diagnostic reagents and assays for testing of body fluid; reagents for use in medical genetic testing; cotton swabs for medical purposes, in International Class 5.”
“Biomedical diagnostic apparatus, namely, food and water safety testing for environmental monitoring; biomedical diagnostic apparatus, namely, molecular diagnostic device used for nucleic acid testing, infectious disease testing, genetic testing, and/or drug response testing for environmental monitoring for research purposes; biomedical devices in the nature of cartridges for loading biological samples for use in molecular diagnostic devices; testing sample collection equipment, namely, swabs for obtaining biological samples from subjects for research purposes, in International Class 9.”
“Biomedical diagnostic apparatus, namely, molecular diagnostic device used for nucleic acid testing, infectious disease testing, genetic testing, and/or drug response testing for environmental monitoring; biomedical devices in the nature of cartridges for loading biological samples for use in molecular diagnostic devices; testing sample collection equipment, namely, swabs for obtaining biological samples from subjects for biomedical purposes, in International Class 10.”
“Biomedical research services; genetic testing for scientific research purposes; scientific research in the field of genetics and genetic engineering, in International Class 42.”
“Medical diagnostic testing, monitoring, and reporting services; medical testing for diagnostic or treatment purposes; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical testing services; medical laboratory services for the analysis of blood samples taken from patients, in International Class 44.”
For assistance with identifying and classifying goods and services in trademark applications, please see the USPTO’s online searchable U.S. Acceptable Identification of Goods and Services Manual. See TMEP §1402.04.
MAY NOT EXPAND THE IDENTIFICATION
How to respond. Click to file a response to this nonfinal Office action.
/Blandu, Florentina/
Examining Attorney
U.S. Patent & Trademark Office
L.O.117
Florentina.Blandu@uspto.gov
Tel 571-272-9128
Fax 571-273-9128
RESPONSE GUIDANCE